Sexual Development is a distinguished peer-reviewed journal published by KARGER, focusing on the intricate biological processes underpinning sexual differentiation and development across various organisms. With an ISSN of 1661-5425 and an E-ISSN of 1661-5433, the journal has established itself as a vital resource for researchers in the fields of Developmental Biology, Embryology, and Endocrinology. Hailing from Basel, Switzerland, this journal is committed to disseminating high-quality research that explores the complexities of sexual development, including genetic, environmental, and hormonal influences. With considerable recognition in the academic community, it currently holds a Q2 ranking in Embryology and Q3 rankings in both Developmental Biology and Endocrinology, Diabetes and Metabolism. Researchers and professionals are encouraged to contribute to and access its wealth of knowledge, thereby advancing understanding and discovery in this critical area of biological research. The journal's continuous publication since 2006 reflects its dedication to evolving the discourse and knowledge base surrounding sexual development, making it an essential platform for scholars in the field.

CURRENT OPINION IN GENETICS & DEVELOPMENT is a prestigious journal published by CURRENT BIOLOGY LTD that offers an insightful platform for the latest developments and emerging trends in the fields of genetics and developmental biology. Established in 1991 and set to continue until at least 2024, this journal achieves notable recognition in the academic community with a Q1 classification in both its major categories as of 2023. With a Scopus rank placing it within the top quartile for both genetics and developmental biology, it serves as an essential resource for researchers, professionals, and students seeking to enhance their understanding of genetic mechanisms and developmental processes. While currently not an open-access journal, readers can explore the collection of high-quality articles that contribute to shaping contemporary scientific discourse and fostering innovation within these dynamic fields. For those dedicated to advancing their research and knowledge, CURRENT OPINION IN GENETICS & DEVELOPMENT stands as a vital and influential academic publication.

GENETICA is a prominent journal published by SPRINGER, dedicated to advancing the field of genetics and its applications across various biological disciplines, including animal science, plant science, and insect science. Since its inception in 1919, the journal has consistently served as a vital platform for researchers and professionals to disseminate high-quality research findings that explore the genetic bases of biological phenomena. With its current scope spanning from 1943 to 2024, GENETICA holds a commendable position in the academic community, as evidenced by its Q2 ranking in both animal science and insect science, and its active contribution to interdisciplinary studies in genetics. Although the journal does not offer open access, it remains accessible through institutional subscriptions and libraries, ensuring its vital research is widely circulated. Researchers, professionals, and students alike will find GENETICA an invaluable resource for the latest discoveries and methodologies in the ever-evolving landscape of genetics.

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

GENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.

Comparative Cytogenetics, an esteemed journal published by PENSOFT PUBLISHERS, is a pivotal resource in the fields of animal science, biotechnology, genetics, insect science, and plant science. Since its inception as an Open Access journal in 2009, it has significantly contributed to the democratization of scientific knowledge, allowing researchers and students across the globe to access cutting-edge developments in cytogenetics. With an impressive range of articles published from 2010 to 2024, this journal has achieved a commendable impact within the academic community, earning a Q3 ranking in Animal Science and Zoology, Biotechnology, and Insect Science, as well as a Q4 ranking in Genetics, indicating its growing influence. Its Scopus rankings reflect a solid standing, with notable percentiles showcasing its relevance across diverse biological sciences. Located in Sofia, Bulgaria, Comparative Cytogenetics serves not only to disseminate research but also to foster collaboration in understanding cytogenetic dynamics, making it an essential platform for professionals, researchers, and students alike.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

GENES CHROMOSOMES & CANCER, published by Wiley, is a premier journal in the intertwined fields of cancer research and genetics. With an ISSN of 1045-2257 and an e-ISSN of 1098-2264, this journal has been a significant outlet for innovative research since its inception in 1989, continuing through to 2024. Positioned in the Q2 quartile of both Cancer Research and Genetics categories in 2023, it reflects a strong impact in the scientific community, as evidenced by its Scopus rankings—99th in Genetics and 83rd in Cancer Research. Though it does not provide open access options, GENES CHROMOSOMES & CANCER offers valuable insights that foster collaboration and discovery among researchers, professionals, and students dedicated to understanding the genetic underpinnings of cancer. With its reputable standing, this journal is a vital resource for those aspiring to contribute meaningful advancements in cancer genetics and therapeutic interventions.

Leukemia Research is a prominent academic journal dedicated to advancing the field of hematology and oncology, focusing on the latest research developments related to leukemia and other hematological disorders. Founded in 1977 and published by Pergamon-Elsevier Science Ltd in the United Kingdom, this esteemed journal has established itself as a vital resource for researchers and clinicians alike. With an impressive impact factor and categorized in the top quartiles of Cancer Research and Hematology, it provides a platform for high-quality research articles, reviews, and clinical studies that contribute to a deeper understanding of leukemia's complexities. Although not an Open Access journal, Leukemia Research ensures widespread dissemination of knowledge crucial for developing innovative treatment strategies and improving patient outcomes. Researchers, professionals, and students in the fields of hematology and oncology will find this journal an invaluable asset in staying at the forefront of leukemia research, as it prepares to expand its impact through converged years of publication extending into 2024.

Cancer Genetics is an esteemed peer-reviewed journal dedicated to advancing the field of cancer research through the lens of genetics. Published by Elsevier Science Inc and available in both print (ISSN: 2210-7762) and online (E-ISSN: 2210-7770), this journal aims to provide a platform for the dissemination of high-quality studies that unravel the genetic underpinnings of cancer. Since its inception in 2011, Cancer Genetics has become a significant resource for researchers, professionals, and students with a shared interest in understanding the intricate relationship between genetics and oncogenesis. With an impact factor that reflects its influence, the journal has maintained a Q3 ranking in Cancer Research, Genetics, and Molecular Biology as of 2023, indicating its growing importance in these fields. Additionally, the journal offers open access options to ensure that crucial findings are easily accessible to the global research community. By bridging the gap between genetics and cancer studies, Cancer Genetics plays a pivotal role in fostering innovation and collaboration among scientists and clinicians striving to improve cancer diagnosis and treatment.